(Q38017721)

27 August 2017

title

Antiparasitical chemotherapy in Chagas' disease cardiomyopathy: current evidence (English)

1 reference

27 August 2017

0 references

1 reference

1 reference

Paulo Marcos Matta Guedes

1

1 reference

27 August 2017

Fredy Roberto Salazar Gutierrez

2

1 reference

27 August 2017

Manuela Sales Lima Nascimento

3

1 reference

27 August 2017

Maria Adelaide Do-Valle-Matta

4

1 reference

27 August 2017

João Santana Silva

5

1 reference

27 August 2017

publication date

12 June 2012

1 reference

Tropical Medicine and International Health

27 August 2017

published in

1 reference

27 August 2017

volume

17

1 reference

27 August 2017

issue

9

1 reference

27 August 2017

page(s)

1057-1065

1 reference

Adverse events after the use of benznidazole in infants and children with Chagas disease

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03025.X

Biodemes and zymodemes of Trypanosoma cruzi strains: correlations with clinical data and experimental pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03025.X

Specific chemotherapy of Chagas disease: a comparison between the response in patients and experimental animals inoculated with the same strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03025.X

Current and developing therapeutic agents in the treatment of Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03025.X

Immunological and clinical evaluation of chagasic patients subjected to chemotherapy during the acute phase of Trypanosoma cruzi infection 14-30 years ago

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03025.X

Persistent infections in chronic Chagas' disease patients treated with anti-Trypanosoma cruzi nitroderivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03025.X

Advances in Chagas disease drug development: 2009-2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03025.X

Molecular diagnosis and treatment monitoring of congenital transmission of Trypanosoma cruzi to twins of a triplet delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03025.X

Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03025.X

In Vitro and In Vivo Studies of the Trypanocidal Properties of WRR-483 against Trypanosoma cruzi

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03025.X

Sensitivity of parasites to free radical damage by antiparasitic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03025.X

Treatment and seroconversion in a cohort of children suffering from recent chronic Chagas infection in Yoro, Honduras

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03025.X

Efficacy of benznidazol treatment for asymptomatic chagasic patients from state of Rio Grande do Sul evaluated during a three years follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03025.X

Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03025.X

Nitric oxide donor trans-[RuCl([15]aneN)NO] as a possible therapeutic approach for Chagas' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03025.X

Current status of Chagas disease chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03025.X

The role of parasite persistence in pathogenesis of Chagas heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03025.X

Correlation between Trypanosoma cruzi parasitism and myocardial inflammatory infiltrate in human chronic chagasic myocarditis: Light microscopy and immunohistochemical findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03025.X

The small GTP-binding protein Rac1 induces cardiac myocyte hypertrophy through the activation of apoptosis signal-regulating kinase 1 and nuclear factor-kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03025.X

Clinical and laboratory status of patients with chronic Chagas disease living in a vector-controlled area in Minas Gerais, Brazil, before and nine years after aetiological treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03025.X

Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03025.X

A comparative study of posaconazole and benznidazole in the prevention of heart damage and promotion of trypanocidal immune response in a murine model of Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03025.X

Clinical and epidemiological aspects of Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03025.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03025.X

Aetiological treatment of congenital Chagas' disease diagnosed and monitored by the polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03025.X

Treatment of Trypanosoma cruzi infection in the undetermined phase. Experience and current guidelines of treatment in Argentina

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03025.X

Longitudinal study and specific chemotherapy in children with chronic Chagas' disease, residing in a low endemicity area of Argentina

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03025.X

Chemotherapy of Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03025.X

Antiparasitic compounds that target DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03025.X

A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03025.X

In vivo detection of Trypanosoma cruzi antigens in hearts of patients with chronic Chagas' heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2012.03025.X

10.1111/J.1365-3156.2012.03025.X

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference